A carregar...
Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder
INTRODUCTION: Approximately 17 million Americans and 300 000 veterans have an alcohol use disorder (AUD). Both oral naltrexone (NTX) and long-acting, injectable naltrexone (LAI NTX) are FDA-approved to treat AUD. LAI NTX is often reserved for patients with adherence concerns due to considerable diff...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007564/ https://ncbi.nlm.nih.gov/pubmed/29955507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.106 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|